Fig. 3From: Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibrationInternalisation assay representing A surface counts, B internal counts, C total counts and D rate of internalisation over 48Â hBack to article page